PetMed Express, Inc. (PETS) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is neutral — 2 Buy, 6 Hold, 2 Sell.
The consensus price target is $11.00 (low: $7.00, high: $19.00), representing an upside of 368.1% from the current price $2.35.
Analysts estimate Earnings Per Share (EPS) of $-0.13 and revenue of $0.27B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.37 vs est $-0.13 (missed -193.8%). 2025: actual $-0.30 vs est $-0.08 (missed -275%). Analyst accuracy: 30%.
PETS Stock — 12-Month Price Forecast
$11.00
▲ +368.09% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for PetMed Express, Inc., the average price target is $11.00, with a high forecast of $19.00, and a low forecast of $7.00.
The average price target represents a +368.09% change from the last price of $2.35.
Highest Price Target
$19.00
Average Price Target
$11.00
Lowest Price Target
$7.00
PETS Analyst Ratings
Hold
Based on 10 analysts giving stock ratings to PetMed Express, Inc. in the past 3 months
EPS Estimates — PETS
30%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.37
vs Est –$0.13
▼ 66.0% off
2025
Actual –$0.30
vs Est –$0.08
▼ 73.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — PETS
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.281B
vs Est $0.271B
▲ 3.7% off
2025
Actual $0.227B
vs Est $0.230B
▼ 1.4% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
